9/11
12:17 pm
avbp
Rating for AVBP
Medium
Report
Rating for AVBP
9/11
12:17 pm
avbp
Rating for AVBP
Medium
Report
Rating for AVBP
9/10
12:10 pm
avbp
ArriVent BioPharma, Inc. (NASDAQ: AVBP) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $39.00 price target on the stock, up previously from $35.00.
Low
Report
ArriVent BioPharma, Inc. (NASDAQ: AVBP) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $39.00 price target on the stock, up previously from $35.00.
9/10
11:22 am
avbp
Rating for AVBP
Low
Report
Rating for AVBP
9/10
11:22 am
avbp
Rating for AVBP
Low
Report
Rating for AVBP
9/10
09:54 am
avbp
Rating for AVBP
Medium
Report
Rating for AVBP
9/10
09:54 am
avbp
Rating for AVBP
Medium
Report
Rating for AVBP
9/10
09:54 am
avbp
Rating for AVBP
Medium
Report
Rating for AVBP
8/15
10:30 am
avbp
ArriVent BioPharma, Inc. (NASDAQ: AVBP) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $35.00 price target on the stock.
Low
Report
ArriVent BioPharma, Inc. (NASDAQ: AVBP) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $35.00 price target on the stock.
8/15
09:52 am
avbp
Rating for AVBP
Low
Report
Rating for AVBP
8/15
09:52 am
avbp
Rating for AVBP
Low
Report
Rating for AVBP